Friday, November 08, 2019 1:40:18 AM
The Bottom-Line for HHSE Management's Initial Plans for the USE OF PROCEEDS from the S-1 Registration is that we are only anticipating a raising of $3-million, even though the S-1 will be available for UP TO $8-Million. This is not due to any skepticism on the value of the offering, but based solely on discussions already in motion for large funding groups (which appear to be accessible for about $3-million into HHSE rather quickly). It's crucial under such registrations to define and adhere to a strict Use of Proceeds, as the inducement for direct purchasers of shares is often based on the company's pledge of specific endeavors. It's also important to note that both investors and regulators resist S-1 fundings which are utilized primarily for the retirement of debts or for the benefit of principals. Generally, those supporting a S-1 offering want to know that the majority of the new funds will go towards generating exciting, new ventures... and not just to pay yesterday's bills. In this respect, as well as the intention to apply some proceeds towards overhead, administration and payables management, HHSE has proposed the following formula for the Initial $3-million to be raised from the S-1:
1). Proceeds Allocated towards Development & Launch of MyFlix: $1,000,000 (33%)
2). Proceeds Allocated towards HHSE Payables / Debt Management: $1,000,000 (33%)
3). Proceeds for Feature Development, Theatrical & Video Activities: $1,000,000 (33%)
It is our position that the allocation of 33% each for MyFlix, Debts and Other Revenue Operations is a reasonable plan to build shareholder value while still empowering management with payables funding for allocation. Clearly, the hot-buttons for new funding are MyFlix AND the high-end films (that, except for reimbursable "development" costs, will be funded through off-balance sheet investment, pre-sales and governmental incentives).
In order to welcome and update some NEW HHSE SHAREHOLDERS that have just joined our team, below is an OVERVIEW of the MyFlix multi-studio streaming venture.
HHSE will also be developing and facilitating the production of several HIGH PROFILE titles that will become the revenue locomotives of the non-MyFlix activities. The titles that have been ANNOUNCED include MELTDOWN, THE LEGEND OF BELLE STARR and MOTHER GOOSE: JOURNEY TO UTOPIA.
WE ARE ASKING FOR SHAREHOLDER COMMENTS TO THIS PROPOSED USE OF PROCEEDS BEFORE WE FINALIZE THE S-1 NARRATIVE AND TABLES. PLEASE EMAIL COMMENTS OR QUESTIONS TO: Eric@HannoverHouse.com
Recent HHSE News
- Form 8-K - Current report • Edgar (US Regulatory) • 01/05/2024 07:17:02 PM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • BLO • Apr 25, 2024 8:52 AM
Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM
Axis Technologies Group and Carbonis Forge Ahead with New Digital Carbon Credit Technology • AXTG • Apr 24, 2024 3:00 AM
North Bay Resources Announces Successful Equipment Test at Bishop Gold Mill, Inyo County, California • NBRI • Apr 23, 2024 9:41 AM
Epazz, Inc.: CryObo, Inc. solar Bitcoin operations will issue tokens • EPAZ • Apr 23, 2024 9:20 AM